The adjusted hazard ratio for developing rectal cancer after radiation therapy was 1.7 (95% CI, 1.4-2.2). This evidence is the most definitive yet to show that prostate irradiation increases risk ...

updated recommendations are presented for the use of radiation therapy (RT) for operable rectal cancer. Jennifer Y. Wo, M.D., from Massachusetts General Hospital in Boston, and colleagues provide ...

Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 373 , 811–820 (2009).

In 2012, at the age of 44, was diagnosed with stage 3c colon cancer. Since then, she has been an advocate for awareness on TikTok.

She was racing around her home in Washington, D.C., to pack for New York, where she had been scheduled to undergo weeks of radiation therapy for rectal cancer. Sascha, then 38, had undergone six ...

They suggest new immunotherapeutic treatment strategies and highlight ... a machine learning model of complete response to radiation in rectal cancer reveals immune infiltrate and TGFβ as key ...

The US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to a cancer drug called dostarlimab (brand name Jemperli) that has so far shown a 100 percent clinical response ...

Ropidoxuridine is under clinical development by Shuttle Pharmaceuticals and currently in Phase I for Rectal Cancer.

IROX does not change, but enriches the treatment algorithm of advanced colorectal cancer at the second-line level. The primary end point was met, with a statistically significant difference in ...

VANCOUVER, BC / ACCESSWIRE / January 8, 2025 / Onco-Innovations Limited (CSE:ONCO)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company") is pleased to provide information on its exclusively-licensed ...